QuantumScape enters its Q2 2026 earnings with a consensus revenue estimate of $1.0 million and an expected EPS loss of $0.18, while the current stock price of $5.86 trades below the average analyst target of $7.88.
Investors are primarily focused on the production ramp of the company's Eagle Line pilot facility and the timeline for QSE-5 cell commercialization.
The report follows a period of bearish technical momentum despite progress in licensing discussions and a recently announced joint research agreement with Honda.
Market participants will also closely scrutinize the company's 2026 adjusted EBITDA loss guidance of $250 million to $275 million to assess the long-term cash runway and capital efficiency.